In the present study we aimed to (a) investigate whether fibrinogen plasma concentrations are elevated in patients with PAH and/or CTEPH, (b) characterise possible differences between patients with PAH and CTEPH regarding fibrinogen plasma concentrations and (c) evaluate a potential association of fibrinogen plasma concentrations with established risk factors for disease progression and severity in both groups.